Cargando…

Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit

Interaction between the epidermal growth factor receptor (EGFR) and the insulin-like growth factor receptor (IGF-1R) has been well established in many cancer types. We investigated the effects of cetuximab (EGFR antibody) and IMC-A12 (IGF-1R antibody) on the response of head and neck squamous cell c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raju, Uma, Molkentine, David P, Valdecanas, David R, Deorukhkar, Amit, Mason, Kathryn A, Buchholz, Thomas A, Meyn, Raymond E, Ang, Kie-Kian, Skinner, Heath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312119/ https://www.ncbi.nlm.nih.gov/pubmed/25355701 http://dx.doi.org/10.1002/cam4.345

Ejemplares similares

p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade
por: Molkentine, David P., et al.
Publicado: (2022)

Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR
por: Aleksic, Tamara, et al.
Publicado: (2016)

Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer
por: Elbaz, Mohamad, et al.
Publicado: (2016)

Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma
por: Xu, Lieyu, et al.
Publicado: (2016)

Adding Concurrent Chemotherapy Significantly Improves the Survival of Stage II-IVb Nasopharyngeal Carcinoma Patients Treated With Concurrent Anti-EGFR Agents
por: Yu, Zi-Kun, et al.
Publicado: (2021)

Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function
por: Kumar, Manish, et al.
Publicado: (2021)

IGF-1 receptor antagonism inhibits autophagy
por: Renna, Maurizio, et al.
Publicado: (2013)

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer
por: Wang, Rong, et al.
Publicado: (2020)

Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer
por: Kang, Jia, et al.
Publicado: (2022)

Identification of Compounds That Inhibit IGF-I Signaling in Hyperglycemia
por: Maile, Laura A., et al.
Publicado: (2009)

Inhibition of Both EGFR and IGF1R Sensitized Prostate Cancer Cells to Radiation by Synergistic Suppression of DNA Homologous Recombination Repair
por: Wang, Yong, et al.
Publicado: (2013)

Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
por: de Groot, Stefanie, et al.
Publicado: (2020)

MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells
por: Bridges, Kathleen A., et al.
Publicado: (2016)

Adding Concurrency to a Sequential Refinement Tower
por: Schellhorn, Gerhard, et al.
Publicado: (2020)

Bosutinib Inhibits EGFR Activation in Head and Neck Cancer
por: Segrelles, Carmen, et al.
Publicado: (2018)

Unexpected responses to EGFR inhibition in NSCLC
por: Stella, Giulia M., et al.
Publicado: (2015)

IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK
por: Lehman, Christine E., et al.
Publicado: (2021)

Epitope-Specific Mechanisms of IGF1R Inhibition by Ganitumab
por: Calzone, Frank J., et al.
Publicado: (2013)

Inhibition of IGF-1 receptor kinase blocks the differentiation into cardiomyocyte-like cells of BMSCs induced by IGF-1
por: Gong, Haibin, et al.
Publicado: (2017)

miR-422a Inhibits Glioma Proliferation and Invasion by Targeting IGF1 and IGF1R
por: Wang, Haiyang, et al.
Publicado: (2017)

Twistor methods for AdS$_5$
por: Adamo, Tim, et al.
Publicado: (2016)

Insulin activates EGFR by stimulating its interaction with IGF-1R in low-EGFR-expressing TNBC cells
por: Shin, Miyoung, et al.
Publicado: (2015)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023)

MicroRNA-7 enhances cytotoxicity induced by gefitinib in non-small cell lung cancer via inhibiting the EGFR and IGF1R signalling pathways
por: Zhao, Jun-gang, et al.
Publicado: (2015)

Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy
por: Madan, Babita, et al.
Publicado: (2018)

Brk/PTK6 Sustains Activated EGFR Signaling through Inhibiting EGFR Degradation and Transactivating EGFR
por: Li, X, et al.
Publicado: (2012)

EGFR monoclonal antibody panitumumab inhibits chronic proliferative cholangitis by downregulating EGFR
por: Liu, San-Hu, et al.
Publicado: (2019)

EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR
por: Novak, D. D., et al.
Publicado: (2023)

Inhibition of Cell Proliferation by an Anti-EGFR Aptamer
por: Li, Na, et al.
Publicado: (2011)

Inhibition of EGFR Signaling Protects from Mucormycosis
por: Watkins, Tonya N., et al.
Publicado: (2018)

Inhibiting IGF1R-mediated Survival Signaling in Head and Neck Cancer with the Peptidomimetic SSTN(IGF1R)
por: Stueven, Noah A., et al.
Publicado: (2023)

Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2019)

CHK1 inhibition exacerbates replication stress induced by IGF blockade
por: Wu, Xiaoning, et al.
Publicado: (2021)

IGF‑1 inhibits palmitic acid‑induced mitochondrial apoptosis in macrophages
por: Tang, Wanying, et al.
Publicado: (2023)

Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors
por: Choi, Yun Jung, et al.
Publicado: (2013)

Lamprey IGF-Binding Protein-3 Has IGF-Dependent and -Independent Actions
por: Zhong, Yingbin, et al.
Publicado: (2017)

miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
por: Sun, Xiaoyan, et al.
Publicado: (2016)

XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer
por: Schanzer, Juergen M., et al.
Publicado: (2016)

MicroRNA 615-3p Inhibits the Tumor Growth and Metastasis of NSCLC via Inhibiting IGF2
por: Liu, Jiangtao, et al.
Publicado: (2019)

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
por: Al-Saad, Samer, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_165p8p5ubgm0ejrhjjl7sqeh61